Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
暂无分享,去创建一个
M. Brin | S. Factor | C. Singer | J. Murray | R. Rodnitzky | C. Comella | J. Wallace | A. Brashear | M. Koller | R. Trosch | C L Comella | R L Rodnitzky | M. Lew | A Brashear | S A Factor | C Singer | M F Lew | M F Brin | D D Dykstra | M Koller | D. Dykstra | J J Murray | R Trosch | J D Wallace | A Willmer-Hulme | A. Willmer-Hulme
[1] C. Marsden,et al. Psychological functioning before and after treatment of torticollis with botulinum toxin. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[2] A J Lees,et al. Botulinum toxin treatment in spasmodic torticollis. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[3] S. Fahn,et al. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A , 1993, Movement disorders : official journal of the Movement Disorder Society.
[4] H. Shibasaki,et al. Optimisation of botulinum treatment for cervical and axial dystonias: experience with a Japanese type A toxin. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[5] A. Lees,et al. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A , 1998, Journal of neurology, neurosurgery, and psychiatry.
[6] A. Eisen,et al. DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS , 1986, The Lancet.
[7] Joseph Jankovic,et al. Mouse bioassay versus Western blot assay for botulinurn toxin antibodies Correlation with clinical response , 1998, Neurology.
[8] H. Sugiyama,et al. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures , 1976, Infection and immunity.
[9] S. Gauthier. Idiopathic Spasmodic Torticollis: Pathophysiology and Treatment , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[10] C. Bertrand,et al. Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases. , 1993, Surgical neurology.
[11] L. Blumhardt,et al. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[12] M. Schulzer,et al. Botulinum toxin type B in the treatment of cervical dystonia , 1995, Neurology.
[13] C. O’Brien,et al. BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A‐Resistant cervical dystonia patients (preliminary study) , 1997, Movement disorders : official journal of the Movement Disorder Society.
[14] M. Brin,et al. Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis , 1990, Neurology.
[15] K. Schwartz,et al. Response and immunoresistance to botulinum toxin injections , 1995, Neurology.
[16] J. Jankovic,et al. Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia , 1997, Neurology.
[17] N. Bathien,et al. Botulinum antibodies in dystonic patients treated with type A botulinum toxin , 1993, Neurology.
[18] F. Benfenati,et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin , 1992, Nature.
[19] J. Jankovic,et al. Cervical dystonia , 1991, Neurology.
[20] S Fahn,et al. Development of resistance to botulinum toxin type A in patients with torticollis , 2004, Movement disorders : official journal of the Movement Disorder Society.
[21] Thomas C. Südhof,et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 , 1993, Nature.
[22] L. S. Siegel. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid , 1989, Journal of clinical microbiology.
[23] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[24] D. Boghen,et al. Effectiveness of botulinum toxin in the treatment of spasmodic torticollis. , 1993, European neurology.
[25] M. Brin,et al. Idiopathic cervical dystonia: Clinical characteristics , 1991, Movement disorders : official journal of the Movement Disorder Society.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[27] V. Braun,et al. Selective peripheral denervation for the treatment of spasmodic torticollis. , 1994, Neurosurgery.
[28] T. Martin. Stages of regulated exocytosis. , 1997, Trends in cell biology.
[29] J. Nutt,et al. Epidemiology of dystonia in Rochester, Minnesota. , 1988, Advances in neurology.